JPRN-UMIN000009576已完成未知
Azilsartan Circadian and Sleep pressure the 1st study - ACS1
ACS Society0 个研究点目标入组 700 人开始时间: 2012年12月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A. Secondary hypertension, grade III hypertension (sitting systolic blood pressure greater than or equal to 180mmHg or sitting diastolic blood pressure greater than or equal to 110mmHg), malignant hypertension B. More than 2 kinds of hypotensive agents for treatment on the hypertension C. History of taking following within 2 weeks before start of the observation period When subject taking any of the following at the time of informed consent is included, stop to take the medicine for determined period after the informed consent. a. Hypotensive agents b. Antianginal agents c. Antiarrhythmic agents (except single time use of the lidocaine hydrochloride formulation for anesthesia) d. Digitalis products D. Less than 130mmHg of mean 24-hour systolic blood pressure and less than 80mmHg of mean 24-hour diastolic blood pressure at the start of the observation period. E. History of following circulatory-related diseases or symptoms within 24 weeks before start of the observation period a. Cardiac disease: Myocardial infarction, coronary artery revascularization b. Cerebrovascular disease: cerebral infarction, cerebral hemorrhage, transient ischemic attack c. Progressive hypertensive retinopathy: hemorrhage, exudation, or papilledema F. History or complication with the following circulatory-related diseases Valvular stenosis, Atrial fibrillation, pharmacotherapy-required angina, congestion heart failure, or cardiac arrhythma, or arteriosclerosis obliterans with symptoms of intermittent claudication et al G. Day/night reversal H. History of hypersensitivity or allergy to Azilsartan, Amlodipine, or related drugs I. Participant in any other clinical research J. Pregnant, possible to pregnancy, or lactating woman K. Mal-control of blood pressure during informed consent to taking hypotensive agent L. Symptoms or abnormalities require the withdrawal as soon as possible during informed consent to taking hypotensive agent M. Any those the investigator or other researchers consider as unsuitable
研究者
相似试验
已完成
不适用
Azilsartan Circadian and Sleep PressureHypertensionNCT01762501Sogo Rinsho Médéfi Co., Ltd.957
已完成
不适用
Azilsartan can restore circadian rhythm of the urinary sodium excretioChronic Kidney Disease (CKD)JPRN-UMIN000009549Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences40
尚未招募
不适用
Effect of the Azilsartan for sleep disordered breathing with hypertensioSleep disordered breathing with hypertensionJPRN-UMIN000014901Fujita Health University60
已完成
不适用
Effect of azilsartan on 24-h ambulatory blood pressure in patients with CKD and hypertension.CKD and hypertensionJPRN-UMIN000012931ephrology and Hypertension, St. Marianna University School of Medicine20
已完成
不适用
Association of Circadian Variations,Sleep Architecture, Hypertension, and Prostaglandin in Sleep ApneaObstructive Sleep ApneaJPRN-UMIN000020202Kyoto University Graduate School of Medicine64